Clinical Trials in Illinois

Showing 15001-15020 of 19,692 trials

Placebo-controlled Proof of Concept Study of Epelsiban in Women With Adenomyosis

NCT02794467

The primary objective of the study is to assess the efficacy, safety, and tolerability of epelsiban compared with placebo in treatment of women with adenomyosis. This is a 12-week, randomized, double-blind, placebo-controlled, parallel group study with an interim futility analysis. Subjects will be randomized 1:1:1 to receive 75 milligrams (mg) of epelsiban three times daily (TID), 200 mg of epelsiban TID, or placebo TID. The study will be composed of three periods: screening, treatment, and follow-up and the total time a subject will be in the study will be approximately 6 months.

Adenomyosis

GlaxoSmithKlineStarted Jul 2016

Washington D.C., District of Columbia, United States • West Palm Beach, Florida, United States • Champaign, Illinois, United States +10 more locations

COMPLETEDPhase 351 miles

Lamotrigine Extended-Release In Elderly Patients With Epilepsy

NCT00516139

This study is being conducted to determine the safety and tolerability of lamotrigine (LTG) in elderly patients with epilepsy. This study will be carried out using an extended-release formulation of lamotrigine (LTG-XR) that will allow once-a-day dosing.

Epilepsy

GlaxoSmithKline122 participantsStarted Aug 2007

Birmingham, Alabama, United States • Gilbert, Arizona, United States • Litchfield Park, Arizona, United States +60 more locations

Placebo-controlled Proof of Concept Study of Epelsiban in Women With Adenomyosis

Lamotrigine Extended-Release In Elderly Patients With Epilepsy

Find Trials by Condition in Illinois

Study Of Asthma In Patients Of African Descent

Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)

Onset Motor Complications Using REQUIP CR (Ropinirole Controlled-release) As Add-on Therapy To L-dopa In Parkinson's

Use of Activated Recombinant FVII in Spinal Surgery

Study Comparing the Immune Response of Fluarix and Fluzone Influenza Vaccines

A Phase 2 Single-Masked, Randomized Study of Latanoprost PPDS in Ocular Hypertension or Open-Angle Glaucoma

A Retrospective Study With Prospective Follow-Up of Complex Ventral Hernia Repair Utilizing the AlloMax Surgical Graft

Maximal Use Systemic Exposure (MUSE) Study of Levulan Kerastick

A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - W0260-301

BMS-188667 in Children and Adolescents With Juvenile Rheumatoid Arthritis

Use Of SB424323 With Aspirin In Non-Valvular Atrial Fibrillation In Patients At A Low Or Intermediate Risk For Stroke

Pediatric Epilepsy Study in Subjects 1-24 Months

Use of Muscle Spectroscopy to Evaluate Mitochondrial Dysfunction in HIV-Infected Patients

A Study To Evaluate The Safety And Tolerability Of PF-06342674 (RN168) In Subjects With Multiple Sclerosis (MS)

Follow-up Study to Assess Visual Function in Subset of Patients Who Have Previously Participated in the TG-MV-006 and TG-MV-007 Ocriplasmin Studies

A Trial of Extracorporeal Photopheresis, Pentostatin, and Total Body Irradiation in Patients Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation for the Treatment of Malignancies

Recombinant Factor VIIa in Acute Intracerebral Haemorrhage

Observational Study on the Effect of NovoMix® 30, Levemir® or NovoRapid® (Alone or Combined) in Type 2 Diabetics Previously Treated With Anti-diabetic Medication